Clinical Trials Logo

NF2 Gene Mutation clinical trials

View clinical trials related to NF2 Gene Mutation.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02523014 Recruiting - Clinical trials for Intracranial Meningioma

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Start date: August 2015
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with meningioma that is growing, spreading, or getting worse (progressive). Vismodegib, FAK inhibitor GSK2256098, capivasertib, and abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.